$36.71 -0.35 (%) Abiomed Inc - NASDAQ

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Vycor Value Could be Unlocked with These Major Partnerships

    GuruFocus | Dec. 5, 2014 | 10:07AM EST
  2. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  3. Medical-Device Stocks Could Benefit From Tax Repeal

    IBD | Nov. 5, 2014 | 17:42PM EST
  4. UPDATE: BTIG Research Downgrades Abiomed As FDA Overhang Is Gone

    Benzinga | Nov. 3, 2014 | 09:47AM EST
  5. Mid-Afternoon Market Update: NASDAQ Climbs 0.55%; Terex Shares Slide After Weak Earnings

    Benzinga | Oct. 30, 2014 | 15:02PM EST
  6. Midday Gainers From October 30: Lakeland Industries, Clean Diesel, Calix And More

    Benzinga | Oct. 30, 2014 | 14:00PM EST
  7. Benzinga's Volume Movers

    Benzinga | Oct. 30, 2014 | 11:01AM EST
  8. Clinical Trial Results For Impella RP Right Ventricular Heart Failure Trial "Recover Right" Released At TCT 2014

    Benzinga | Sep. 16, 2014 | 17:05PM EST
  9. Wall Street Comfortable With Covidien Buy; Some See Move By Johnson & Johnson

    Benzinga | Jun. 16, 2014 | 16:29PM EST
  10. Abiomed Acquires Exclusive License for Opsens' Optical Sensor Technology

    Benzinga | Apr. 15, 2014 | 08:03AM EST
  11. UPDATE: Benchmark Initiates Coverage on Abiomed on Potential of Impella Device

    Benzinga | Oct. 1, 2013 | 08:57AM EST
  12. Abiomed Wins Federal Contract to Provide Impalla Platform to Vets

    Benzinga | Aug. 26, 2013 | 08:05AM EST
  13. Abiomed profit dips on costs

    IBD | Aug. 1, 2013 | 19:22PM EST
  14. Mid-Day Market Update: Markets Largely Flat, Groupon Boosts

    Benzinga | Dec. 7, 2012 | 06:06AM EST
  15. Abiomed Shares Lower as FDA Panel Votes to Retain Class III Status for Ventricular Support Devices

    Benzinga | Dec. 7, 2012 | 04:30AM EST
  16. Medical Device Makers: Repeal the New Tax!

    FoxBusiness | Nov. 28, 2012 | 01:43AM EST
  17. Abiomed Says Class Action Lawsuit Without Merit; Intends to Defend Vigorously

    Benzinga | Nov. 16, 2012 | 11:53AM EST
  18. Benzinga's Top Initiations

    Benzinga | Nov. 9, 2012 | 00:57AM EST
  19. ABIOMED Plunges After Revealing Government Investigation; Stock Loses 33%

    Benzinga | Nov. 1, 2012 | 11:15AM EST
  20. Benzinga Mid-Day Market Update

    Benzinga | Nov. 1, 2012 | 10:08AM EST
  21. Lennar, Other Homebuilders Crush Profit Estimates

    IBD | Aug. 21, 2012 | 05:16AM EST
  22. Health Care Sector Wrap

    FoxBusiness | Aug. 20, 2012 | 10:51AM EST
  23. Health Care Sector Wrap

    FoxBusiness | Aug. 17, 2012 | 10:42AM EST
  24. ABIOMED Inc. (ABMD) CFO Robert Bowen sells 15,000 Shares

    GuruFocus | Aug. 8, 2012 | 14:29PM EST
  25. Abiomed heart pump sales pop

    IBD | Aug. 2, 2012 | 12:39PM EST
  26. Abiomed's Heart Pumps Pound Q1 Expectations

    IBD | Aug. 2, 2012 | 11:43AM EST
  27. Abiomed Earnings Beat Estimates, But Shares Fall

    IBD | Aug. 2, 2012 | 05:01AM EST
  28. Abiomed Earnings Beat Estimates, But Shares Fall

    IBD | Aug. 2, 2012 | 05:01AM EST
  29. Thoratec Reports Mixed Q2; Abiomed Waits In Wings

    IBD | Aug. 1, 2012 | 11:06AM EST
  30. Weekly CFO Sells Highlight: BDSI, LNKD, VRSK, ABMD, AGX

    GuruFocus | Jul. 17, 2012 | 07:18AM EST
  31. ABIOMED Inc. (ABMD) CFO Robert Bowen sells 16,715 Shares

    GuruFocus | Jul. 16, 2012 | 13:18PM EST
  32. ABIOMED Inc. (ABMD) CFO Robert Bowen sells 8,556 Shares

    GuruFocus | Jul. 13, 2012 | 12:12PM EST
  33. ABIOMED Inc. (ABMD) CFO Robert Bowen sells 7,316 Shares

    GuruFocus | Jun. 6, 2012 | 13:23PM EST
  34. UPDATE: Piper Jaffray Raises Price Target on Abiomed to $27

    Benzinga | May. 17, 2012 | 01:32AM EST
  35. UPDATE: Wunderlich Securities Raises PT to $29 on Abiomed; Impella Exceeds Expectations

    Benzinga | May. 17, 2012 | 01:31AM EST
  36. Abiomed expects strong sales

    IBD | May. 16, 2012 | 12:59PM EST
  37. Abiomed Stock Reverses From High Despite Strong Sales

    IBD | May. 16, 2012 | 08:46AM EST
  38. Abiomed Stock Hits High After Q4 Sales Top Estimates

    IBD | May. 16, 2012 | 05:03AM EST
  39. Earnings Scheduled For May 16

    Benzinga | May. 15, 2012 | 21:17PM EST
  40. Notable Call Options Activity in Abiomed

    Benzinga | Feb. 6, 2012 | 07:13AM EST
  41. UPDATE: Piper Jaffray Raises PT to $25 on ABIOMED

    Benzinga | Feb. 6, 2012 | 02:16AM EST
  42. UPDATE: Wunderlich Securities Raises PT on Abiomed to $27

    Benzinga | Feb. 5, 2012 | 23:15PM EST
  43. Wunderlich Raises PT on Abiomed to $27

    Benzinga | Feb. 5, 2012 | 23:06PM EST
  44. Wunderlich Securities Maintains Buy Rating on Abiomed

    Benzinga | Dec. 23, 2011 | 01:31AM EST
  45. Rodman & Renshaw Downgrades Abiomed to Market Underperform

    Benzinga | Dec. 19, 2011 | 00:40AM EST
  46. Abiomed Announces Expanded Heart Recovery Strategy with Multi Year Growth Initiatives

    Benzinga | Dec. 9, 2011 | 07:03AM EST
Trading Center